Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-24

Clinical Trial Update: PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluated the combination of PIPAC and FOLFOX for gastric cancer with peritoneal carcinomatosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOLFOX
  • PIPAC (Pressurized intraperitoneal aerosol chemotherapy)

Snippet

Sponsor: Vilnius University | Conditions: Gastric Cancer, Peritoneal Carcinomatosis | NA | Status: COMPLETED